Sarepta Therapeutics Inc. (SRPT) gapped open sharply higher Thursday and climbed in early trade, before settling into a range. Shares finished up by 1.80 at $14.40 on above average volume.
Sarepta Therapeutics has been gaining ground for the past 3 weeks and set a new high for the year. Thursday's surge in stock price was attributed to a television report which stated that the company's Eteplirsen drug for muscle weakness and loss of muscle tissue has shown positive signs in one patient.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.